University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Medial Versus Lateral Approach in Ultrasound (US)-Guided Supraclavicular Block

Not Applicable

Completed

Conditions: Hand or Arm Surgery

Interventions: Procedure: Media-to-Lateral Approach
Procedure: Lateral-to-Medial Approach

First Posted Date: 2009-10-09

Last Posted Date: 2017-12-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 78

Registration Number: NCT00992810

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Measurement of Forces Applied Using a Macintosh Direct Laryngoscope Compared to GlideScope Video Laryngoscope

Not Applicable

Completed

Conditions: Endotracheal Intubation
Laryngoscopy

Interventions: Device: Macintosh (direct vision) laryngoscope
Device: GlideScope videolaryngoscope (indirect vision)

First Posted Date: 2009-10-09

Last Posted Date: 2011-04-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 70

Registration Number: NCT00992628

Locations: 🇨🇦
Toronto General Hospital, UHN, Toronto, Ontario, Canada
🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

Phase 1

Completed

Conditions: Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Hodgkin's Disease
Myelodysplasia
Acute Myeloid Leukemia
Hematologic Malignancy
Chronic Myelogenous Leukemia

Interventions: Drug: Ciclopirox Olamine

First Posted Date: 2009-10-07

Last Posted Date: 2015-06-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT00990587

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Phase 1

Completed

Conditions: Lymphoma
Myeloma
Leukemia
Hodgkin's Disease

Interventions: Biological: NK-92 cells

First Posted Date: 2009-10-07

Last Posted Date: 2016-06-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 8

Registration Number: NCT00990717

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Topical Tranexamic Acid for Total Knee Arthroplasty

Phase 4

Completed

Conditions: Surgical Blood Loss
Total Knee Arthroplasty

Interventions: Drug: Placebo
Drug: tranexamic acid

First Posted Date: 2009-09-29

Last Posted Date: 2011-04-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 125

Registration Number: NCT00985920

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Stereotactic Radiosurgery With Sunitinib for Brain Metastases

Phase 1

Completed

Conditions: Brain Metastases

Interventions: Drug: Sunitinib

First Posted Date: 2009-09-22

Last Posted Date: 2022-10-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 22

Registration Number: NCT00981890

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

Colorectal Cancer Screening for Cancer Survivors

Completed

Conditions: Colorectal Cancer

Interventions: Other: Colonoscopic examination

First Posted Date: 2009-09-22

Last Posted Date: 2018-01-31

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 140

Registration Number: NCT00982059

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Concurrent Boost Radiotherapy

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Radiation: Concurrent Boost RT

First Posted Date: 2009-09-22

Last Posted Date: 2012-12-21

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 17

Registration Number: NCT00981864

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Procedure: BOLD MRI test

First Posted Date: 2009-08-21

Last Posted Date: 2017-10-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 80

Registration Number: NCT00963612

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Phase 1

Terminated

Conditions: Lymphoma, Non-Hodgkin
Myelodysplasia
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma

Interventions: Drug: Clioquinol

First Posted Date: 2009-08-21

Last Posted Date: 2015-06-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 11

Registration Number: NCT00963495

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy